sermorelin-injection.com is published by the Executive Medical, LLC editorial team as an independent, US-focused reference site on sermorelin and adjacent growth-hormone-releasing peptide therapies. The brief is straightforward: explain the pharmacology, the regulatory landscape, and the way modern telehealth practices have built workflows around compounded products, in language a careful general reader can follow.
Editorial purpose. Sermorelin sits at an unusual intersection of endocrinology, compounding pharmacy regulation, and direct-to-consumer telehealth. Coverage in the mainstream press tends to be either uncritical promotional material or dismissive in a way that does not engage with the actual science. We wanted a single reference site that walks through the topic in measured, sourced prose: what the molecule does, how it differs from somatropin, what 503A and 503B compounding actually mean in 2026, how a state-licensed clinician evaluates whether the therapy is appropriate, and what monitoring looks like after the first prescription. The articles are written for adults eighteen and over who are trying to understand the subject for themselves.
Sources and review process. Each article begins as an outline that maps claims to source material: peer-reviewed studies, FDA guidance documents, statements from professional societies such as the Endocrine Society and the American Society of Health-System Pharmacists, and the public dockets of the Pharmacy Compounding Advisory Committee. The first draft is written by a staff editor, fact-checked against those primary sources, and then read by a second editor who is responsible for catching unsupported claims, regulatory imprecision and language that could be mistaken for individualized advice. Citations are kept inline where they are load-bearing; broader background material is summarized in the prose. When a study cited in an article is later retracted, contradicted or superseded, the article is updated and a dated note is added.
Editorial independence.
Reaching the editorial team. Press inquiries, source pitches, correction requests and reader questions can all be sent through the contact form. The form routes directly to the editorial mailbox; we do not have a separate sales or business-development queue. For postal correspondence the office is at Ready Health Ventures Inc., 1007 N Orange St. 4th Floor Ste 1382, Wilmington, Delaware, 19801, and for time-sensitive matters the phone line is .
What sermorelin injection actually is
For adults across the United States, USA, sermorelin is a 29-amino-acid peptide that mimics the first portion of natural growth hormone releasing hormone (GHRH). When injected subcutaneously, sermorelin signals the pituitary gland to release the body's own growth hormone in a pulsatile, physiologic pattern. This is the key difference from synthetic human growth hormone (HGH): sermorelin asks the body to produce its own GH, rather than supplying GH from outside.
Because of that mechanism, sermorelin therapy is typically prescribed for adults whose GH output has declined with age. It is dispensed in the United States as a compounded subcutaneous injection from licensed 503A and 503B pharmacies, and it requires a written prescription from a clinician after consultation and lab work.
How treatment is initiated in the United States, USA
- Intake and lab order. You complete a health history online. A licensed clinician orders a baseline blood panel that includes IGF-1, fasting glucose and a complete metabolic profile.
- Clinical review. A US-licensed clinician reviews your labs against your goals and confirms that sermorelin is medically appropriate. If it is not, the consultation is refunded in full.
- Compounded prescription. The prescription is written to a partner compounding pharmacy. Sermorelin is shipped to your address across the United States, USA with syringes, alcohol pads and dosing instructions.
- Self-administration. Most protocols use a single subcutaneous injection at night, on an empty stomach, to align with natural GH pulse. A 1:1 health coach is included to walk you through the first weeks.
Who tends to consider sermorelin
Residents of the United States typically enter consultation between 30 and 65 years old, when the downstream effects of declining growth hormone output begin to surface. The most common reasons people pursue sermorelin are listed below.
- Reduced recovery from training, harder to gain or hold lean mass
- Sleep that feels lighter and less restorative than it used to
- Visible changes in body composition, especially abdominal fat
- Lower energy in the late afternoon and softer libido
- Slower healing from minor injuries, joint and connective tissue discomfort
- Mental fog or reduced focus across the day
None of these reasons in isolation is a diagnosis. They are screening signals that justify a real clinical conversation, lab work and a personalized protocol. Sermorelin is not prescribed for performance enhancement and is not marketed for cosmetic anti-aging.
Frequently asked questions
How long until results appear?
Most reported changes follow a predictable curve. Sleep depth and morning energy typically shift in the first 30 days. Skin, hair and metabolic markers tend to move in the second month. Body composition, libido and joint comfort are usually evaluated at the three month mark, when a follow-up lab is recommended.
Is sermorelin the same as HGH?
No. HGH is the growth hormone molecule itself. Sermorelin is a releasing peptide that prompts the body to produce its own GH in a natural pulsatile rhythm. This avoids the supraphysiological peaks that direct HGH injection can produce.
Is sermorelin FDA approved?
The original brand version of sermorelin was discontinued. The form prescribed today is a compounded medication dispensed by licensed compounding pharmacies under federal sections 503A and 503B. Compounded preparations are not separately FDA approved, and that disclosure is provided at consultation.
Is sermorelin legal in my state?
Sermorelin is legal across the United States when prescribed by a US-licensed clinician. Each state medical board sets its own scope-of-practice rules, but compounded sermorelin dispensed under federal 503A and 503B is permitted across all 50 states.
Do I need insurance?
No. Most patients pay out of pocket. HSA and FSA cards are accepted by most telehealth providers. The consultation, labs and three month supply are usually billed as a single program.
Where do I inject?
Subcutaneous injection into the abdomen at least one inch from the navel, or into the outer thigh. The injection is small (insulin syringe gauge), administered nightly on an empty stomach. The protocol is typically five days on, two days off.
What if treatment is not appropriate for me?
If the clinician reviewing your intake decides sermorelin is not medically necessary, the consultation fee is refunded in full and no prescription is issued. This is built into the licensed telehealth model and is verifiable in the provider's terms.
Ready to speak with a clinician in the United States, USA
The consultation is online, the lab can be drawn at home, and treatment ships to your door if you qualify.
Start your consultation